Author: Shelby Benavidez
Contributing Attorney: Brad Russell, attorney
According to the investigation, UnitedHealth Group, one of the largest healthcare companies in the United States, is being accused of exaggerating client diagnoses in its Medicare Advantage business in order to receive a higher payout from the government. This insurance company is currently under both criminal and civil investigation by the U.S. Department of Justice (DOJ). The investigation has major implications for the company, of course, but also for the millions of Americans who rely on Medicare Advantage for their healthcare. In this article, we will break down what the investigation is about, who’s involved, why it matters, and what’s happening now.
UnitedHealth and Medicare Advantage: Key Background
What is UnitedHealth Group and Its Role in Healthcare?
UnitedHealth Group is the parent company of UnitedHealthcare, which is one of the biggest health insurers in the country. It serves tens of millions of people through private insurance, employer-based plans, and government programs like Medicare and Medicaid. In addition to health insurance, the company also owns Optum, a large healthcare services arm that provides pharmacy benefits, data analytics, and direct medical care.
UnitedHealth is so large that it plays a major role in the American healthcare system. What happens to the company has a ripple effect across patients, providers, and even the overall cost of healthcare in the U.S.
Medicare Advantage Explained: How the Program Works
Medicare Advantage (MA) is a private alternative to traditional Medicare. Instead of the government directly paying doctors and hospitals, the government pays insurance companies like UnitedHealth a set amount for each person who enrolls in this benefit plan. These insurers then manage patients’ care and benefits.
As many people know, insurance companies can deny patients for pre-existing conditions or refuse to cover patients that are high-risk. The Medicare Advantage plan was intended to prevent insurers from cherry-picking healthy patients, incentivizing them to cover those who really need it. The sicker a patient is, the more insurers are paid. This is where “risk adjustment” comes in. If a patient has more serious conditions, the insurance company receives higher payments to cover the expected costs of care.
Medicare Advantage Risk Adjustment and Why It Matters
While risk adjustment was created to protect patients with serious health conditions, it’s been a motivator for manipulation. Once the insurance company learns they will receive a bigger payout for patients with serious medical conditions, they may exaggerate their insured’s condition. This deception is often referred to as “upcoding.”
Some people are disturbed by this practice, saying that upcoding cheats taxpayers and inflates healthcare costs. Others defend the insurance company, arguing that coding is complex and mistakes can be made accidentally. Regardless, upcoding is ultimately the root of the investigation against UnitedHealth. The DOJ investigation is focused on whether the company deliberately exaggerated patient conditions to boost revenue, or if it was genuinely an honest mistake.
UnitedHealth Investigation: DOJ Medicare Fraud Probe
DOJ and FBI Leading the UnitedHealth Investigation
The U.S. Department of Justice is leading the investigation with both the civil division and the criminal healthcare fraud unit involved. Agencies like the FBI and the Department of Health and Human Services (HHS) Office of Inspector General are also playing a role. Criminal investigations in the healthcare industry are relatively rare, especially for companies as large as UnitedHealth, which shows how extreme this case really is.
Why UnitedHealth Is Under DOJ Investigation
Allegedly, former employees, including doctors and nurses, came forward with concerns, claiming that UnitedHealth encouraged or pressured staff to record certain diagnoses that would raise their reimbursement rates. Examples included conditions like peripheral artery disease and secondary hyperaldosteronism, which are serious conditions that typically require extensive medical treatment.
These practices first caught the attention of journalists in 2024. By mid-2025, the DOJ had formally requested documents and launched interviews. UnitedHealth itself acknowledged in July 2025 that it’s cooperating with both criminal and civil investigations.
UnitedHealth Responds to DOJ Investigation Claims
While they claim to be cooperating with the investigation, UnitedHealth continues to deny any wrongdoing. The company insists that it has followed federal guidelines and points to independent audits showing no evidence of fraud. It also emphasizes that Medicare regulators, including the Centers for Medicare & Medicaid Services (CMS), have reviewed its practices in the past without finding violations.
In addition, UnitedHealth has launched its own third-party investigations. These investigations are looking into its risk adjustment coding, managed care practices, and pharmacy services. The company says it wants to improve transparency and reassure the public.
Why the UnitedHealth Investigation Matters for Patients and Taxpayers
How the UnitedHealth Investigation Could Affect Patients
For patients, the immediate concern is whether their care could be affected. Investigations like this usually don’t disrupt day-to-day medical services. However, if UnitedHealth faces fines or restrictions, it could eventually influence plan options, premiums, or benefits. Medicare Advantage enrollees, in particular, should be watching closely.
UnitedHealth Medicare Probe and Taxpayer Costs
Medicare is funded by taxpayers, so the stakes are high. If companies are inflating diagnoses to increase payments, billions of taxpayer dollars could be wasted. That’s why regulators are taking this issue so seriously. Even small increases in coding can add up quickly when applied across millions of patients.
What the UnitedHealth Case Means for Medicare Advantage
The UnitedHealth case is part of a larger debate about Medicare Advantage. Critics argue that the program has become a cash cow for insurers, who may prioritize profits over patient care. Supporters, on the other hand, argue that Medicare Advantage often provides more benefits than traditional Medicare and can improve care coordination.
The outcome of this investigation could shape future regulations. If the DOJ finds wrongdoing, it may push for stricter oversight of Medicare Advantage plans across the industry. Other insurers are likely watching this case closely, since many have faced similar accusations of upcoding.
Other Medicare Fraud Cases: Kaiser, Cigna, Sutter Health
UnitedHealth Lawsuits and Past Medicare Billing Cases
Before the current criminal accusations, UnitedHealth had already faced civil lawsuits under the False Claims Act. In 2017, the DOJ accused the company of knowingly submitting inaccurate information about patient diagnoses to inflate Medicare payments. Whistleblowers alleged that UnitedHealth failed to correct errors even after audits flagged problems. Although that earlier case did not result in criminal charges, it laid the foundation for today’s more serious investigation.
Kaiser Permanente and Cigna Medicare Fraud Allegations
Other major insurers have also faced scrutiny. In 2023, Kaiser Permanente faced claims that it knowingly submitted false diagnosis codes to boost Medicare Advantage payments. Prosecutors said Kaiser pressured doctors to add extra conditions that weren’t supported by medical records. Cigna has also been accused in multiple lawsuits of using home visits by nurses to gather questionable diagnoses, which the government argued led to billions in improper payments. Cigna denies wrongdoing, but the legal battles continue.
Sutter Health $90M Medicare Fraud Settlement
The issue extends beyond insurers to healthcare providers as well. In 2021, Sutter Health, a large hospital system in California, agreed to pay $90 million to settle allegations that it submitted unsupported diagnosis codes for Medicare Advantage patients. This demonstrated how both insurers and healthcare systems may benefit financially from the way risk adjustment is structured.
Current Status of DOJ’s UnitedHealth Investigation
Ongoing DOJ and Medicare Fraud Investigations
The DOJ’s investigation is still ongoing, and no charges have been filed yet. However, the fact that both civil and criminal investigations are underway suggests the government is considering serious action. UnitedHealth has faced civil lawsuits in the past related to Medicare billing, but the involvement of the criminal division sets this case apart.
Possible Outcomes of the UnitedHealth DOJ Investigation
The possible outcomes of the investigation vary. One possibility is that UnitedHealth could face civil penalties, including fines or an order to repay Medicare funds if overbilling is proven. Another is that investigators could pursue criminal charges. If evidence shows intentional fraud, executives or employees could be prosecuted. A third possible outcome is increased oversight, with regulators imposing stricter auditing and reporting requirements on the company. Any of these outcomes could affect not only UnitedHealth but also the Medicare Advantage program nationwide.
What to Watch for in the UnitedHealth Medicare Fraud Case
The coming months will be important in determining how the investigation unfolds. Observers will be watching to see if the DOJ files charges or negotiates a settlement. Attention will also focus on how UnitedHealth’s third-party investigations are received by regulators, and whether Congress takes further action to reform Medicare Advantage. For patients and taxpayers, the central question is whether the system will become more transparent and accountable.
Key Takeaways from the UnitedHealth DOJ Investigation
The criminal and civil investigations into UnitedHealth’s Medicare Advantage business highlight serious questions about how America’s largest insurers manage taxpayer-funded healthcare. At the heart of the case is a simple but powerful issue: are companies fairly reporting patients’ conditions, or are they exaggerating them to increase profits?
While UnitedHealth has denied wrongdoing and pledged cooperation, the stakes are enormous. The outcome of this case could shape not just the future of UnitedHealth but also the rules governing Medicare Advantage as a whole. For now, patients, taxpayers, and policymakers are left waiting to see how one of the biggest healthcare investigations in years will unfold.
